Tg Therapeutics annual gross margin
2021
2022
2023
2024
2025
Tg Therapeutics Gross Margin Growth & History (TGTX)
Tg Therapeutics's gross margin was 83.66% for fiscal 2025.
View full Tg Therapeutics company overviewTg Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 83.66% | −4.64 pp |
| 2024 | 2024-12-31 | 88.30% | −5.65 pp |
| 2023 | 2023-12-31 | 93.95% | +3.47 pp |
| 2022 | 2022-12-31 | 90.48% | +2.30 pp |
| 2021 | 2021-12-31 | 88.19% | — |
Tg Therapeutics quarterly gross margin
Q1.21
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 82.86% | −3.72 pp |
| Q1 2026 | 2026-03-31 | 83.65% | −3.49 pp |
| Q4 2025 | 2025-12-31 | 80.19% | −5.57 pp |
| Q3 2025 | 2025-09-30 | 82.63% | −6.24 pp |
| Q2 2025 | 2025-06-30 | 86.58% | −2.11 pp |
| Q1 2025 | 2025-03-31 | 87.14% | −4.29 pp |
| Q4 2024 | 2024-12-31 | 85.77% | +3.63 pp |
| Q3 2024 | 2024-09-30 | 88.86% | −9.02 pp |
| Q2 2024 | 2024-06-30 | 88.70% | +0.59 pp |
| Q1 2024 | 2024-03-31 | 91.43% | +2.41 pp |
| Q4 2023 | 2023-12-31 | 82.14% | — |
| Q3 2023 | 2023-09-30 | 97.88% | +0.01 pp |
| Q2 2023 | 2023-06-30 | 88.11% | — |
| Q1 2023 | 2023-03-31 | 89.02% | — |
| Q3 2022 | 2022-09-30 | 97.87% | — |
| Q1 2021 | 2021-03-31 | 82.47% | — |
Tg Therapeutics gross margin trends
Between the periods ended 2021-12-31 and 2025-12-31, Tg Therapeutics's gross margin decreased from 88.19% to 83.66%, a change of −4.53 percentage points. The latest reported quarter, Q2 2026, shows 82.86%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tg Therapeutics source filings ↗